Check out our most popular compounded medications! Get Started
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded oral liquid containing betamethasone, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products containing betamethasone are listed in cream, ointment, aerosol, injection, lotion and suspension forms.
Liquid bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.
Betamethasone is a potent synthetic corticosteroid that compounding pharmacies prepare as topical creams, ointments, lotions and solutions by prescription.
Betamethasone is a synthetic glucocorticoid, a man-made version of the adrenal hormone cortisol. It calms inflammation, itching and immune activity, and on the skin it also narrows small blood vessels and slows cell turnover. It is used as different esters: betamethasone dipropionate and valerate on the skin, and a sodium phosphate and acetate mix by injection. Diprolene Ointment (Organon), a super-high-potency topical corticosteroid, is FDA-approved for the inflammatory and itchy symptoms of corticosteroid-responsive skin conditions in patients 13 and older. Celestone Soluspan injectable suspension (Organon) is approved for a long list of allergic, skin, endocrine, joint, blood, eye, kidney, lung and other conditions, including intralesional and joint injection. A prescriber may order betamethasone compounded in a vehicle, strength or combination not manufactured. Compounded preparations are not FDA-approved and require a prescription.
Betamethasone does not carry a boxed warning. On the skin, high-potency products can suppress the body's own steroid production (HPA axis suppression), especially with large areas, wraps or occlusion, long use, broken skin, liver failure or use in children; they may also raise the risk of cataracts and glaucoma. Avoid the face, groin and armpits and any area of thinned skin, and do not bandage the area unless told to. Thinning skin, stretch marks, acne and color changes can occur. Do not use it if you are allergic to betamethasone or other corticosteroids. The injection label warns of serious nerve injuries, some fatal, after epidural injection; it is contraindicated by intramuscular injection in idiopathic thrombocytopenic purpura, and it raises infection risk, including severe chickenpox or measles. Systemic corticosteroids appear in breast milk, and LactMed prefers shorter-acting alternatives for systemic use. For use on the skin, LactMed says to use the least potent drug on the smallest area, keep the infant from touching treated skin, and avoid applying it to the nipple. For skin changes or vision problems, talk to your prescriber or pharmacist.
Betamethasone acts through the glucocorticoid receptor. Topically, StatPearls describes anti-inflammatory effects (upper dermal vasoconstriction, lipocortin-mediated phospholipase A2 inhibition and NF-kB suppression), antimitotic and immunosuppressive effects. Potency depends on ester and vehicle: augmented betamethasone dipropionate ointment and gel are class I (superpotent), betamethasone dipropionate ointment is class II, and betamethasone valerate cream, lotion and foam are medium potency. Ointments and occlusion increase absorption. In Celestone Soluspan, the soluble sodium phosphate ester gives prompt activity and the slightly soluble acetate gives sustained activity. Labeled indications include corticosteroid-responsive dermatoses (Diprolene Ointment, age 13 and older) and the systemic, intra-articular, soft tissue and intralesional uses listed for Celestone Soluspan, such as keloids, alopecia areata and acute gouty arthritis. Dosing per prescriber. StatPearls advises limiting high-potency topical courses and tapering, and considering HPA axis testing with potent steroids over large areas; monitor for atrophy, striae, hyperglycemia and ocular effects. With systemic use, watch for infection, hepatitis B reactivation and adrenal insufficiency after withdrawal. Betamethasone is not a controlled substance.
Shake the bottle if your label says to. Measure each dose with the oral syringe or dosing cup the pharmacy gave you, never a kitchen spoon. Give the liquid slowly into the mouth. Rinse the syringe with water after each use. Call the pharmacy if you are unsure how to measure.
Storage depends on the vehicle. Water-based liquids with a preservative usually carry a USP <795> beyond-use date of up to 35 days; without a preservative they are kept refrigerated for up to 14 days. Oil-based (nonaqueous) oral liquids may carry up to 90 days. Your label states whether to refrigerate and the beyond-use date. Keep out of reach of children and discard after that date.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
